about
Chagas disease in the 21st century: a public health success or an emerging threat?Management of trypanosomiasis and leishmaniasisParasitic Infections in Hematopoietic Stem Cell TransplantationImmunosuppression and Chagas disease: a management challengeInhibition of poly(ADP-ribose) polymerase interferes with Trypanosoma cruzi infection and proliferation of the parasiteAptamer-based detection of disease biomarkers in mouse models for chagas drug discoveryActivities of psilostachyin A and cynaropicrin against Trypanosoma cruzi in vitro and in vivo.Genetic dissection of drug resistance in trypanosomesVaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infectionLimited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging.Therapy of chagas disease: implications for levels of prevention.Opportunities and challenges in chronic Chagas cardiomyopathyDesigned compounds for recognition of 10 base pairs of DNA with two at binding sites.Mapping inhibitor binding modes on an active cysteine protease via nuclear magnetic resonance spectroscopyThe absence of myocardial calcium-independent phospholipase A2γ results in impaired prostaglandin E2 production and decreased survival in mice with acute Trypanosoma cruzi infection.Aptamer based, non-PCR, non-serological detection of Chagas disease biomarkers in Trypanosoma cruzi infected mice.Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy.In vitro activity of 1,3-bisaryloxypropanamines against Trypanosoma cruzi-infected L929 cultures.Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruziChagas disease in non-endemic countries: epidemiology, clinical presentation and treatment.Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.3-Hydroxykynurenine, a Tryptophan Metabolite Generated during the Infection, Is Active Against Trypanosoma cruzi.Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine.Parasitic infections in solid organ transplantation.Potential mechanism of the anti-trypanosomal activity of organoruthenium complexes with bioactive thiosemicarbazones.Water-soluble ruthenium complexes bearing activity against protozoan parasites.Expanding the knowledge of the chemical structure of glycoconjugates from Trypanosoma cruzi TcI genotype. Contribution to taxonomic studies.Trypanosoma cruzi Exploits Wnt Signaling Pathway to Promote Its Intracellular Replication in Macrophages.The Presence and Extension of Myocardial Fibrosis in the Undetermined Form of Chagas' Disease: A Study Using Magnetic Resonance.A new ruthenium cyclopentadienyl azole compound with activity on tumor cell lines and trypanosomatid parasites
P2860
Q24594371-53DECFED-22C5-46A3-B07E-E111B187B98BQ24596889-088C8E90-BA66-405C-B684-3F6E15F94032Q26740380-F661FFB0-08BC-48CF-8C95-C7D762B68A4AQ26863357-20E2FEC0-70AB-40FA-8A72-59734F601ACEQ28483989-3BDDF05D-2F2B-433A-8B98-A862F0584A00Q28542996-67C7BE41-43E7-4A44-90E6-9C5F74B46CB9Q34363646-E4D8A9EA-44B3-4BFB-887D-54BDD947E61CQ34647009-10EC2DE8-A698-4E4F-B619-3C80886C2B27Q34700649-EA3CCC2F-6EF9-4F5A-BDBD-F7A252A1676CQ35859935-1D6D7EEB-A9A0-45B9-B660-F3B31A5E4E1FQ35864834-85121997-0EA8-4474-8D61-957D93D241A7Q36108560-B9A8708E-8B78-434C-8703-08C198B65CCDQ36479273-B973805F-1053-4C7B-A02F-BA4BA9D24CC8Q36593560-F639C48B-1C85-4BBD-AEF0-8899FCB49D8DQ36970825-703F707D-104B-43A2-AF2A-FBDB83553B07Q37488022-2E757575-A9B8-4D60-8AB3-49551C1BB695Q38695350-B6F06644-BB3B-40DE-8384-69090071E507Q38865455-18824145-A5E6-4451-9F2E-27441F9578D0Q38919697-99909E8C-B7A1-445E-A6F2-6E32A881128AQ39372756-F2602DFD-DEB1-431A-A0F8-DD219AF17240Q39444127-4D090D04-C8AC-4F08-B147-356068C8F36AQ40121346-32E4AE47-2B5C-47CA-8E60-815F33E773DFQ41898218-8762CD05-CB26-4BEF-A722-8F5FE81BE389Q42272278-131B262E-AECD-4620-966E-FCA815AEFA55Q46735046-07EAC21D-DB86-4D6E-8022-EB93BAB6404FQ51244607-7773D3FA-ACF7-45C6-A81B-2AF227ABB4B8Q53042397-0C5770ED-79A1-4D03-8C85-AD5944FA3DF0Q55314147-3B6A32BD-C68A-44CC-B6B1-AAE9E17C5BA8Q55399969-D324EE96-F870-4C16-AE77-12019B0DDE4FQ59082746-94EB51FC-89B0-487C-B840-20AAC07841A0
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Update in treatment of Chagas disease.
@en
Update in treatment of Chagas disease.
@nl
type
label
Update in treatment of Chagas disease.
@en
Update in treatment of Chagas disease.
@nl
prefLabel
Update in treatment of Chagas disease.
@en
Update in treatment of Chagas disease.
@nl
P2093
P1476
Update in treatment of Chagas disease.
@en
P2093
François Xavier Lescure
Gilles Pialoux
Guillaume Le Loup
P304
P356
10.1097/QCO.0B013E32834A667F
P577
2011-10-01T00:00:00Z